- Home
- SVRA vs BBW Comparison
SVRA vs BBW Comparison
Compare SVRA & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- BBW
- Stock Information
- Founded
- SVRA 2007
- BBW 1997
- Country
- SVRA United States
- BBW United States
- Employees
- SVRA N/A
- BBW N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- BBW Recreational Games/Products/Toys
- Sector
- SVRA Health Care
- BBW Consumer Discretionary
- Exchange
- SVRA Nasdaq
- BBW Nasdaq
- Market Cap
- SVRA 505.8M
- BBW 464.1M
- IPO Year
- SVRA N/A
- BBW 2004
- Fundamental
- Price
- SVRA $3.00
- BBW $35.36
- Analyst Decision
- SVRA Buy
- BBW Strong Buy
- Analyst Count
- SVRA 6
- BBW 3
- Target Price
- SVRA $8.83
- BBW $54.33
- AVG Volume (30 Days)
- SVRA 615.8K
- BBW 307.7K
- Earning Date
- SVRA 05-16-2025
- BBW 05-29-2025
- Dividend Yield
- SVRA N/A
- BBW 2.48%
- EPS Growth
- SVRA N/A
- BBW 4.11
- EPS
- SVRA N/A
- BBW 3.80
- Revenue
- SVRA N/A
- BBW $496,404,000.00
- Revenue This Year
- SVRA N/A
- BBW $5.54
- Revenue Next Year
- SVRA N/A
- BBW $3.77
- P/E Ratio
- SVRA N/A
- BBW $9.51
- Revenue Growth
- SVRA N/A
- BBW 2.12
- 52 Week Low
- SVRA $2.26
- BBW $23.63
- 52 Week High
- SVRA $5.31
- BBW $48.23
- Technical
- Relative Strength Index (RSI)
- SVRA 47.98
- BBW 47.13
- Support Level
- SVRA $3.12
- BBW $33.45
- Resistance Level
- SVRA $3.56
- BBW $37.25
- Average True Range (ATR)
- SVRA 0.15
- BBW 1.63
- MACD
- SVRA -0.01
- BBW 0.17
- Stochastic Oscillator
- SVRA 21.19
- BBW 57.70
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About BBW Build-A-Bear Workshop Inc.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.